Plamen Bokov1, Asmae
Zakaria2, Berengere Koehl3, Malika
Benkerrou4 and Christophe Delclaux1
1: Paris University, AP-HP, Robert Debré
Hospital, Department of Physiology, INSERM NeuroDiderot, F-75019 Paris,
France
2: Department of Physiology, AP-HP, Robert Debré
Hospital, F-75019 Paris, France
3: Paris University, AP-HP, Robert Debré Hospital,
Sickle Cell Disease Center, Hematology Unit, F-75019 Paris ; UMR_S1134,
BIGR, INSERM, Institut National de la Transfusion Sanguine, Laboratoire
d’Excellence GR-Ex, F-75015 Paris, France
4: Sickle Cell Disease Center, Hematology Unit, Robert
Debré Hospital, AP-HP, F-75019 Paris; INSERM UMR 1123, ECEVE, F-75010
Paris, France
Funding sources: no funding
Conflict of interests: the authors declare no conflict of interest
Table 1 . Clinical, biological and functional characteristics of
the 43 patients with SCD at their initial evaluation.